X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis

Journal of Biological Chemistry

Volumn 288, Issue 28, 2013, Pages 20238-20247

  Cao, Zipeng ^a,b   Zhang, Ruowen ^a   Li, Jingxia ^a   Huang, Haishan ^a,c   Zhang, Dongyun ^a   Zhang, Jingjie ^a   Gao, Jimin ^c   Chen, Jingyuan ^b   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL BEHAVIOR; CANCER DEVELOPMENT; CATALYTIC SUBUNITS; CYCLIN D1 PROTEIN; DOWNSTREAM TARGET; PROTEIN PHOSPHATASE 2A; THERAPEUTIC TARGETS; X-LINKED INHIBITOR OF APOPTOSIS;

ANCHORAGES (FOUNDATIONS); CELL ADHESION; CELL GROWTH; DISEASES; ENZYME INHIBITION; GROWTH KINETICS; PHOSPHATASES; PHOSPHORYLATION; PROTEINS;

CELLS;

CYCLIN D1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UBIQUITIN PROTEIN LIGASE E3; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ANCHORAGE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AP-1 TRANSCRIPTION FACTOR; CYCLIN D1; E3 UBIQUITIN LIGASE; PP2A; XIAP;

BINDING SITES; BLOTTING, WESTERN; CELL ADHESION; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S PHASE; TRANSCRIPTION FACTOR AP-1; TYROSINE; UBIQUITIN-PROTEIN LIGASES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84880048084     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.448365     Document Type: Article

References (55)

1. Srinivasula, S. M., and Ashwell, J. D. (2008) IAPs: what's in a name? Mol. Cell 30, 123-135 (Pubitemid 351626688)
2. Krajewska, M., Krajewski, S., Banares, S., Huang, X., Turner, B., Bubendorf, L., Kallioniemi, O. P., Shabaik, A., Vitiello, A., Peehl, D., Gao, G. J., and Reed, J. C. (2003) Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin. Cancer Res. 9, 4914-4925 (Pubitemid 37323298)
3. Byrd, J. C., Kitada, S., Flinn, I. W., Aron, J. L., Pearson, M., Lucas, D., and Reed, J. C. (2002) The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood 99, 1038-1043 (Pubitemid 34525569)
4. Akyurek, N., Ren, Y., Rassidakis, G. Z., Schlette, E. J., and Medeiros, L. J. (2006) Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer 107, 1844-1851 (Pubitemid 44582954)
5. Kluger, H. M., McCarthy, M. M., Alvero, A. B., Sznol, M., Ariyan, S., Camp, R. L., Rimm, D. L., and Mor, G. (2007) The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitization. J. Transl. Med. 5, 6
6. Nagi, C., Xiao, G. Q., Li, G., Genden, E., and Burstein, D. E. (2007) Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma. Ann. Diagn. Pathol. 11, 402-406 (Pubitemid 350088531)
7. Nemoto, T., Kitagawa, M., Hasegawa, M., Ikeda, S., Akashi, T., Takizawa, T., Hirokawa, K., and Koike, M. (2004) Expression of IAP family proteins in esophageal cancer. Exp. Mol. Pathol. 76, 253-259 (Pubitemid 38569787)
8. Fong, W. G., Liston, P., Rajcan-Separovic, E., St Jean, M., Craig, C., and Korneluk, R. G. (2000) Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70, 113-122
9. Yang, L., Cao, Z., Yan, H., and Wood, W. C. (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63, 6815-6824 (Pubitemid 37322964)
10. Holcik, M., Gibson, H., and Korneluk, R. G. (2001) XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6, 253-261 (Pubitemid 32708519)
11. Tong, Q. S., Zheng, L. D., Wang, L., Zeng, F. Q., Chen, F. M., Dong, J. H., and Lu, G. C. (2005) Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells. Cancer Gene Ther. 12, 509-514 (Pubitemid 40629341)
12. Liu, J., Zhang, D., Luo, W., Yu, Y., Yu, J., Li, J., Zhang, X., Zhang, B., Chen, J., Wu, X. R., Rosas-Acosta, G., and Huang, C. (2011) X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J. Biol. Chem. 286, 15630-15640
13. Schimmer, A. D., Dalili, S., Batey, R. A., and Riedl, S. J. (2006) Targeting XIAP for the treatment of malignancy. Cell Death Differ. 13, 179-188 (Pubitemid 43102202)
14. Suzuki, Y., Nakabayashi, Y., and Takahashi, R. (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. U.S.A. 98, 8662-8667 (Pubitemid 32678084)
15. Gyrd-Hansen, M., and Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nat. Rev. Cancer 10, 561-574
16. Liu, J., Zhang, D., Luo, W., Yu, J., Li, J., Yu, Y., Zhang, X., Chen, J., Wu, X. R., and Huang, C. (2012) E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity. PLoS One 7, e35682
17. Yu, J., Zhang, D., Liu, J., Li, J., Yu, Y., Wu, X. R., and Huang, C. (2012) RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility. J. Biol. Chem. 287, 13752-13760
18. Cordon-Cardo, C. (1995) Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 147, 545-560
19. Fu, M., Wang, C., Li, Z., Sakamaki, T., and Pestell, R. G. (2004) Minireview: cyclin D1: normal and abnormal functions. Endocrinology 145, 5439-5447 (Pubitemid 39564581)
20. Knudsen, K. E., Diehl, J. A., Haiman, C. A., and Knudsen, E. S. (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25, 1620-1628
21. Che, Y., Ye, F., Xu, R., Qing, H., Wang, X., Yin, F., Cui, M., Burstein, D., Jiang, B., and Zhang, D. Y. (2012) Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Am. J. Pathol. 180, 1798-1807
22. Zhang, D., Song, L., Li, J., Wu, K., and Huang, C. (2006) Coordination of JNK1 and JNK2 is critical for GADD45α induction and its mediated cell apoptosis in arsenite responses. J. Biol. Chem. 281, 34113-34123 (Pubitemid 46036620)
23. Ouyang, W., Ma, Q., Li, J., Zhang, D., Liu, Z. G., Rustgi, A. K., and Huang, C. (2005) Cyclin D1 induction through IκB kinase β/nuclear factor-κB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 65, 9287-9293 (Pubitemid 41507995)
24. Wang, J., Ouyang, W., Li, J., Wei, L., Ma, Q., Zhang, Z., Tong, Q., He, J., and Huang, C. (2005) Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor κB induced by UV radiation. Cancer Res. 65, 6601-6611 (Pubitemid 41060696)
25. Luo, W., Liu, J., Li, J., Zhang, D., Liu, M., Addo, J. K., Patil, S., Zhang, L., Yu, J., Buolamwini, J. K., Chen, J., and Huang, C. (2008) Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway. J. Biol. Chem. 283, 8624-8633
26. Zhang, D., Li, J., Wu, K., Ouyang, W., Ding, J., Liu, Z. G., Costa, M., and Huang, C. (2007) JNK1, but not JNK2, is required for COX-2 induction by nickel compounds. Carcinogenesis 28, 883-891 (Pubitemid 46523344)
27. Ouyang, W., Luo, W., Zhang, D., Jian, J., Ma, Q., Li, J., Shi, X., Chen, J., Gao, J., and Huang, C. (2008) PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation. Environ. Health Perspect. 116, 1-6
28. Song, L., Li, J., Zhang, D., Liu, Z. G., Ye, J., Zhan, Q., Shen, H. M., Whiteman, M., and Huang, C. (2006) IKKβ programs to turn on the GADD45α- MKK4-JNK apoptotic cascade specifically via p50 NF-κB in arsenite response. J. Cell Biol. 175, 607-617 (Pubitemid 44790614)
29. Song, L., Li, J., Ye, J., Yu, G., Ding, J., Zhang, D., Ouyang, W., Dong, Z., Kim, S. O., and Huang, C. (2007) p85α acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol. Cell. Biol. 27, 2713-2731 (Pubitemid 46581360)
30. Li, J., Chen, H., Tang, M. S., Shi, X., Amin, S., Desai, D., Costa, M., and Huang, C. (2004) PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J. Cell Biol. 165, 77-86 (Pubitemid 38649178)
31. Huang, C., Ma, W. Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. (1997) Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 94, 5826-5830 (Pubitemid 27241856)
32. Huang, C., Ma, W. Y., Maxiner, A., Sun, Y., and Dong, Z. (1999) p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J. Biol. Chem. 274, 12229-12235
33. Dubrez-Daloz, L., Dupoux, A., and Cartier, J. (2008) IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 7, 1036-1046
34. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., and Ashwell, J. D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877 (Pubitemid 30257739)
35. Sherr, C. J. (1994) G1 phase progression: cycling on cue. Cell 79, 551-555
36. Shaulian, E., and Karin, M. (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400 (Pubitemid 32531297)
37. Zhang, D., Li, J., Gao, J., and Huang, C. (2009) c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells. Toxicol. Appl. Pharmacol. 235, 18-24
38. Lu, M., Lin, S. C., Huang, Y., Kang, Y. J., Rich, R., Lo, Y. C., Myszka, D., Han, J., and Wu, H. (2007) XIAP induces NF-κB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell 26, 689-702 (Pubitemid 46856243)
39. Cooper, S. J., MacGowan, J., Ranger-Moore, J., Young, M. R., Colburn, N. H., and Bowden, G. T. (2003) Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol. Cancer Res. 1, 848-854 (Pubitemid 37174456)
40. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486
41. Al-Murrani, S. W., Woodgett, J. R., and Damuni, Z. (1999) Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity. Biochem. J. 341, 293-298 (Pubitemid 29373652)
42. Chen, J., Parsons, S., and Brautigan, D. L. (1994) Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269, 7957-7962 (Pubitemid 24200196)
43. O'Shaughnessy, R. F., Welti, J. C., Sully, K., and Byrne, C. (2009) Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development. Development 136, 3423-3431
44. Alberts, A. S., Deng, T., Lin, A., Meinkoth, J. L., Schönthal, A., Mumby, M. C., Karin, M., and Feramisco, J. R. (1993) Protein phosphatase 2A potentiates activity of promoters containing AP-1-binding elements. Mol. Cell. Biol. 13, 2104-2112 (Pubitemid 23097689)
45. Arber, N., Doki, Y., Han, E. K., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T., Klein, M. G., Holt, P. R., and Weinstein, I. B. (1997) Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57, 1569-1574 (Pubitemid 27175576)
46. Eckelman, B. P., Salvesen, G. S., and Scott, F. L. (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988-994 (Pubitemid 44480512)
47. Wang, R., Li, B., Wang, X., Lin, F., Gao, P., Cheng, S. Y., and Zhang, H. Z. (2009) Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line. Auris Nasus Larynx 36, 332-339
48. Ma, J. J., Chen, B. L., and Xin, X. Y. (2009) XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 146, 222-226
49. Arber, N., Hibshoosh, H., Moss, S. F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I. B., and Holt, P. R. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110, 669-674 (Pubitemid 26071834)
50. Palmqvist, R., Rutegar̂d, J. N., Bozoky, B., Landberg, G., and Stenling, R. (2000) Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am. J. Pathol. 157, 1947-1953
51. Sherr, C. J., and Roberts, J. M. (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18, 2699-2711 (Pubitemid 39507762)
52. Kozar, K., and Sicinski, P. (2005) Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 4, 388-391 (Pubitemid 41359721)
53. Neil, J. R., Tian, M., and Schiemann, W. P. (2009) X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-β-mediated nuclear factor-κB activation during breast cancer progression. J. Biol. Chem. 284, 21209-21217
54. Bai, Y., Yang, C., Hu, K., Elly, C., and Liu, Y. C. (2004) Itch E3 ligase-mediated regulation of TGF-β signaling by modulating smad2 phosphorylation. Mol. Cell 15, 825-831 (Pubitemid 39194911)
55. Zhang, J., Ouyang, W., Li, J., Zhang, D., Yu, Y., Wang, Y., Li, X., and Huang, C. (2012) Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability. Toxicol. Appl. Pharmacol. 263, 218-224